cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.21804615.v1
title: ExtFig3C_WB_Xrn1_293Tcells_R3_LG116.tif

description: <em>Protein lysates were collected from A549 and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804618.v1
title: ExtFig3C_WB_Xrn1_293Tcells_R3_LG116.sgd

description: <em>Protein lysates were collected from A549 and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804546
title: ExtFig3A_RACE_INSIG1_SLC7A5_R2_LG292.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804546.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R2_LG292.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804549
title: ExtFig3A_RACE_BCAP31_R3_LG293.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804621
title: ExtFig3C_WB_Xrn1_293Tcells_R3_LG116_merge.tif

description: <em>Protein lysates were collected from A549 and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804621.v1
title: ExtFig3C_WB_Xrn1_293Tcells_R3_LG116_merge.tif

description: <em>Protein lysates were collected from A549 and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804549.v1
title: ExtFig3A_RACE_BCAP31_R3_LG293.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804552
title: ExtFig3A_RACE_TUBA1B_R2_LG292.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804552.v1
title: ExtFig3A_RACE_TUBA1B_R2_LG292.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804555.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R3_LG293.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804558
title: ExtFig3A_RACE_TUBA1B_R3_LG293_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804558.v1
title: ExtFig3A_RACE_TUBA1B_R3_LG293_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804555
title: ExtFig3A_RACE_INSIG1_SLC7A5_R3_LG293.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804561
title: ExtFig3A_RACE_INSIG1_SLC7A5_R1_LG290.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804561.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R1_LG290.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804564
title: ExtFig3A_RACE_TUBA1B_R3_LG293.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804564.v1
title: ExtFig3A_RACE_TUBA1B_R3_LG293.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804567
title: ExtFig3A_RACE_TUBA1B_R2_LG292_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804567.v1
title: ExtFig3A_RACE_TUBA1B_R2_LG292_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804570
title: ExtFig3A_RACE_TUBA1B_R3_LG293.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804570.v1
title: ExtFig3A_RACE_TUBA1B_R3_LG293.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804573
title: ExtFig3A_RACE_TUBA1B_R2_LG292.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804573.v1
title: ExtFig3A_RACE_TUBA1B_R2_LG292.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804513
title: ExtFig3A_RACE_BCAP31_R3_LG293_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804513.v1
title: ExtFig3A_RACE_BCAP31_R3_LG293_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804516.v1
title: ExtFig3A_RACE_BCAP31_R3_LG293.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804519
title: ExtFig3A_RACE_BCAP31_R2_LG292.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804519.v1
title: ExtFig3A_RACE_BCAP31_R2_LG292.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804516
title: ExtFig3A_RACE_BCAP31_R3_LG293.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804522
title: ExtFig3A_RACE_BCAP31_R2_LG292_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804525
title: ExtFig3A_RACE_BCAP31_R2_LG292.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804525.v1
title: ExtFig3A_RACE_BCAP31_R2_LG292.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804528
title: ExtFig3A_RACE_INSIG1_SLC7A5_R3_LG293_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804522.v1
title: ExtFig3A_RACE_BCAP31_R2_LG292_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804528.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R3_LG293_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804531
title: ExtFig3A_RACE_INSIG1_SLC7A5_R2_LG292_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804531.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R2_LG292_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804537
title: ExtFig3A_RACE_INSIG1_SLC7A5_R1_LG290.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804537.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R1_LG290.sgd

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804540
title: ExtFig3A_RACE_INSIG1_SLC7A5_R1_LG290_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804534
title: ExtFig3A_RACE_INSIG1_SLC7A5_R2_LG292.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804534.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R2_LG292.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804540.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R1_LG290_annotated.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804543
title: ExtFig3A_RACE_INSIG1_SLC7A5_R3_LG293.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804474
title: ExtFig1C-ExtFig3C_WB_Tubulin_R2_LG369.sgd

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804474.v1
title: ExtFig1C-ExtFig3C_WB_Tubulin_R2_LG369.sgd

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804477
title: ExtFig1C-ExtFig3C_WB_Tubulin_R1_LG246.sgd

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804477.v1
title: ExtFig1C-ExtFig3C_WB_Tubulin_R1_LG246.sgd

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804480
title: ExtFig1C-ExtFig3C_WB_Tubulin_R1_LG246_merge_annotated.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804480.v1
title: ExtFig1C-ExtFig3C_WB_Tubulin_R1_LG246_merge_annotated.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804483
title: ExtFig1C-ExtFig3C_WB_Tubulin_R1_LG246.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804543.v1
title: ExtFig3A_RACE_INSIG1_SLC7A5_R3_LG293.tiff

description: <em>Xrn1 knock out A549 cells were infected with WT PR8 or PR8-PA(∆X), or mock infected. 5’ RACE was then performed using primers specific for BCAP31, TUBA1B, INSIG1 or SLC7A5, positioned ~ 200-300 nucleotides downstream of the predicted cut sites.The PCR products were run on an agarose gel. </em>
DOI: 10.6084/m9.figshare.21804483.v1
title: ExtFig1C-ExtFig3C_WB_Tubulin_R1_LG246.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804486
title: ExtFig1C-ExtFig3C_WB_Tubulin_R2_LG369_merge_annotated.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804486.v1
title: ExtFig1C-ExtFig3C_WB_Tubulin_R2_LG369_merge_annotated.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804492
title: ExtFig1C-ExtFig3C_WB_Xrn1_R1_LG246_merge_annotated.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804492.v1
title: ExtFig1C-ExtFig3C_WB_Xrn1_R1_LG246_merge_annotated.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804489
title: ExtFig1C-ExtFig3C_WB_Tubulin_R2_LG369.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804489.v1
title: ExtFig1C-ExtFig3C_WB_Tubulin_R2_LG369.tiff

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804495
title: ExtFig1C-ExtFig3C_WB_Xrn1_R1_LG246.sgd

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>
DOI: 10.6084/m9.figshare.21804495.v1
title: ExtFig1C-ExtFig3C_WB_Xrn1_R1_LG246.sgd

description: <em>Protein lysates were collected from WT or Xrn1 ko A549 cells and HEKT293T ishXrn1 cells treated with doxycycline for 3-4 days or left untreated. They were then probed with antibodies against Xrn1 or beta-tubulin as a loading control, to check for efficient knock out/down of Xrn1. </em>